Compugen Ltd. (CGEN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-03
(Q2 2026)
— full calendar
Earnings Reports
-
CGEN Q1 2026: $134.9M Cash Runway Extends Pipeline Visibility to 2029
May 18, 2026
-
CompuGen (CGEN) Q4 2025: $65M AstraZeneca Infusion Extends Cash Runway to 2029, Anchoring Pipeline Execution
March 02, 2026
-
Webull (CGEN) Q3 2025: Operating Margin Expands 28.7 Points as Product and Global Scale Drive Leverage
November 21, 2025
-
ComputeGen (CGEN) Q2 2025: $93.9M Cash Runway Extends to 2027 as Pipeline Execution Intensifies
August 06, 2025